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A leaky blood-brain barrier has long been implicated in cognitive dysfunction in aging and neurodegenera-
tion, but reliable human data were lacking. Here, Montagne et al. (2015) provide the first in vivo evidence
of blood-brain barrier disruption in the aging hippocampus and in minimal cognitive impairment.Over 100 years ago, Paul Ehrlich discov-
ered serendipitously that the brain of
animals injected in the bloodstream with
a blue dye was not stained blue like other
organs, and that dyes injected directly
into the brain did not reach the blood-
stream (Hawkins and Davis, 2005). This
fundamental observation led to the
realization that the brain is shielded by
a seemingly impenetrable barrier, the
blood-brain barrier (BBB). Central to the
BBB are unique features of cerebral
endothelial cells, which are adjoined and
sealed by specialized junctions (tight
junctions, TJ) and exhibit minimal vesicu-
lar transport (transcytosis) preventing the
passage of hydrophilic molecules from
blood to brain and vice versa (Obermeier
et al., 2013). Rather, an intricate system
of transporters regulates the bidirectional
traffic of substances across the barrier
according to the metabolic needs of the
brain (Neuwelt et al., 2011). Owing to its
critical role in safeguarding the homeosta-
sis of the brain’s microenvironment, it has
long been postulated that alterations in
the BBB may partake in brain diseases,
including the cognitive dysfunction asso-
ciated with aging and Alzheimer’s demen-
tia (AD) (Zlokovic, 2008). However, due to
the lack of suitable methods to assess
BBB integrity quantitatively and regionally
in the human brain in vivo, it has been
challenging to demonstrate disruptions
of the BBB affecting brain regions
involved in cognition. In this issue of
Neuron, Montagne et al., (2015) provide
the most direct evidence to date of BBB
disruption restricted to the hippocampus
in aging and in patients with minimal
cognitive impairment (MCI), who are
at increased risk for AD. The findings
provide a glimpse into a previously unrec-ognized determinant of hippocampal
dysfunction in humans and suggest novel
biomarkers and therapeutic targets for
cognitive dysfunction.
Some studies of the BBB in aging and
dementia have relied on autopsy material
in which the extravasation of plasma
proteins, such as albumin or fibrinogen,
was detected qualitatively in selected
brain regions by immunocytochemistry
(Zlokovic, 2008). Other studies have
used the concentration ratio of albumin
in cerebrospinal fluid (CSF) and plasma
as a more quantitative index of BBB
permeability. Since albumin does not
normally cross the BBB, increased CSF
concentrations suggest BBB disruption
(Rosenberg, 2012). However, these ap-
proaches are not ideal: in post-mortem
brains, tissue degradation, advanced
disease, and coexisting pathologies com-
plicate establishing cause-effect relation-
ships, while the CSF/plasma albumin
ratio cannot pinpoint the site(s) of BBB
disruption. More recently, imaging
methods based on the brain penetration
of gadolinium, a contrast agent used in
magnetic resonance imaging (MRI), have
been introduced (Rosenberg, 2012), but
the resolution of the images was not suffi-
cient to detect BBB changes in regions
involved in cognitive processing, such as
the hippocampus. Building on these pre-
vious imaging studies, Montagne et al.
developed a high-resolution MRI method
to simultaneously map the blood-to-brain
transfer constant of gadolinium (Ktrans)
regionally and quantitatively, and with a
resolution sufficient to image discrete
regions of the hippocampus. Using this
approach, they generated Ktrans brain
maps in cognitively normal individuals at
different ages (23 to 91 years), and inNeuron 85patients with MCI. In the hippocampus,
mainly CA1 and dentate gyrus, they found
that Ktrans increases linearly with age. In
subjects with MCI, however, the Ktrans
increases were about 60% larger than
those seen in cognitively intact age
matched controls. These increases in
permeability were not associated with
reduced hippocampal volume, suggest-
ing that they preceded the development
of tissue damage and hippocampal
atrophy. Supporting the validity of the
method, in cognitively intact subjects
with multiple sclerosis, the Ktrans in-
creases were present only in the white
matter, where BBB disruption is well
described (Zlokovic, 2008). These obser-
vations provide the first direct evidence
for an age-dependent and regionally
selective disruption of the BBB in the
hippocampus of cognitively normal indi-
viduals, which is exacerbated in MCI.
To gain a mechanistic insight into
the processes underlying the BBB alter-
ations, the authors also examined CSF
biomarkers of BBB permeability and
vascular damage. Hippocampal Ktrans
was well correlated with an increase in
CSF/plasma albumin ratio, but not with
markers of inflammation and neuronal or
endothelial damage, nor with enzymes
involved in BBB disruption, such as
metalloproteinase-9 (MMP9) (Zlokovic,
2008). Interestingly, a strong association
was observed between the increase in
Ktrans and the levels of the soluble form of
the platelet growth factor receptor-b
(PDGFRb), a receptor enriched in peri-
cytes. Pericytes are contractile vascular
cells enveloped by the endothelial base-
mentmembraneof capillaries andparticu-
larly abundant in brain (Armulik et al.,
2011). Recent evidence indicates that, January 21, 2015 ª2015 Elsevier Inc. 231
Figure 1. Hypothetical Mechanisms by which Ab May Induce BBB Alterations and
Hippocampal Dysfunction
Abdamagespericytes leading to suppressionofmfsd2aexpression in endothelial cells and increasedendo-
thelial vesicular transport. Ab also causes endothelial Ca2+ overload through activation of TRPM2 channels,
which contributes to the BBB disruption. Vascular damage reduces Ab clearance and promotes tau phos-
phorylation. The alteration in homeostasis caused by the BBB disruption, in concert with the deleterious ef-
fects of Ab and tau on synaptic function, may result in hippocampal dysfunction and cognitive deficits.
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and maintenance of the BBB and may
even regulate microvascular blood flow
(Armulik et al., 2011; Hall et al., 2014).
Montagne et al. demonstrated that peri-
cytes in culture shed PDGFRb in condi-
tions of severe hypoxia or exposure to
high concentrations of amyloid-b (Ab), a
key pathogenic factor in AD. They also
observed increases in CSF PDGFRb in
mouse models with BBB leakage due to
pericyte damage. On these bases, it is
conceivable that the increase in PDGFRb
found in aged individuals andMCI reflects
pericyte damage, which, in turn, may un-
derlie the disruption of the BBB (Figure 1).
Further studies validatingCSFPDGFRbas
a marker of cerebrovascular health would
be important to assess its usefulness as a
research tool and disease biomarker.
How does gadolinium cross the BBB?
Since gadolinium tends to bind to plasma
proteins, the assessment of the BBB
using this contrast medium reflects brain
entry of relatively large molecules. There-232 Neuron 85, January 21, 2015 ª2015 Elsefore, the blood-to-brain transfer is likely
to be mediated by bulk flow through leaky
TJ or increased transcytosis. MMP9, a
proteolytic enzyme involved in basement
membrane and TJ disruption in ischemic
injury (Iadecola, 2013), was not increased
in the CSF, suggesting that massive
vascular damage may not play a role.
However, it would be of interest to also
examine MMP2, which has been more
directly linked to the BBB leakage associ-
ated with cognitive impairment (Rosen-
berg, 2012). If pericyte damage is
involved, a likely mechanism is increased
bulk flow transcytosis (Armulik et al.,
2011). Pericyte may regulate vesicular
transport by inducing the expression of
the major facilitator super family domain
containing 2a (mfsd2a) in endothelial
cells, which suppresses vesicular trans-
port (Ben-Zvi et al., 2014). Accordingly,
pericyte loss could reduce the endo-
thelial expression of mfsd2a, resulting in
increased transcytosis and gadolinium
transport across the BBB (Figure 1). Onvier Inc.the other hand, since pericytes have also
been implicated in TJ stabilization (Armu-
lik et al., 2011), entry of gadolinium
through leaky TJ cannot be ruled out.
What causes the age-dependent BBB
disruption and preferential localization to
the hippocampus? Since the hippocam-
pus and entorhinal cortex are sites of early
pathology in aging and AD (Braak and
Braak, 1991), it is reasonable to speculate
that Ab or tau could have a role. While
taucannot becompletely excluded, Ab ac-
cumulates earlier than tau, is toxic to peri-
cytes (Verbeek et al., 1997), and can
induce cerebral endothelial dysfunction,
including increased BBB permeability, by
activation of transient receptor potential
melastatin-2 channels (TRPM-2) and dys-
regulation of endothelial intracellular Ca2+
(Park et al., 2014). Another question con-
cerns how a leaky BBB in the hippocam-
pus promotes cognitive decline. Several
mechanisms could be involved, including
entry of toxins andplasmaproteins (hemo-
siderin, thrombin, plasmin), ionic imbal-
ance, activation of microglia, and cytokine
production (Obermeier et al., 2013; Neu-
welt et al., 2011). The study of Montagne
et al. suggests that the hippocampus can
tolerate a certain degree of BBB dysfunc-
tion with no impact on cognitive perfor-
mance. Thus, in normal aging there is a
robust increase in BBB permeability
without impaired cognition, whereas in
MCI the BBB disruption, albeit more pro-
nounced, is associated with cognitive
impairment. It remains unclear what tips
the balance toward impaired cognition.
Although ‘‘cognitive reserves’’ may allow
certain individuals to tolerate more pathol-
ogy before exhibiting cognitive decline,
one possibility is that the hippocampal
dysfunction caused by the BBB alteration
is compensated up to a certain level,
which,whenexceeded, results in cognitive
impairment. Another possibility is that the
BBB disruption alone is not sufficient to
induce hippocampal dysfunction, and
that concomitant pathogenic factors
intrinsic to the hippocampus are also
needed. For example, as stated above,
Ab could damage pericytes and endothe-
lial cells leading to the BBB disruption
(Figure 1). In turn, the BBB disruption and
pericyte loss could alter the brain clear-
ance of Ab and promote Ab accumulation
and tau hyperphosphorylation (Sagare
et al., 2013), factors well known to exert
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hippocampal dysfunction (Spires-Jones
and Hyman, 2014) (Figure 1). Recently
introduced methods for amyloid and tau
imaging in humans could provide insight
into the interaction between AD pathology
andBBBdisruption (Spires-Jones andHy-
man, 2014).
Owing to the cross-sectional design of
the study, the evolution in space and
time of the BBB alterations could not be
assessed in individual subjects. Although
Montagne et al. focused on cognitively
normal or mildly affected subjects, it
would be of instructive to examine the
spatiotemporal evolution of the BBB
alterations in MCI patients who go on to
develop frank AD. Recent data indicate
thatADpathology and theassociated syn-
aptic dysfunction spread throughout the
brain according to a stereotyped pattern,
largely reflecting neuronal connectivity
(Spires-Jones and Hyman, 2014). It would
be informative to determine if the BBB
alteration follows a similar progression
and, if so, whether it precedes or follows
the spread of amyloid and tau.
Another question concerns the role
of BBB disruption in white matter patho-
logy. Subcortical white matter lesions,
assumed to be on ischemic bases, are
common in older subjects and are animportant correlate of cognitive decline
in aging, MCI, and AD (Iadecola, 2013).
Although less pronounced than in the
hippocampus, Montagne et al. observed
a trend for increased permeability in the
white matter, especially in MCI, raising
the possibility that BBB leakage and
not ischemia is an early determinant of
white matter damage. Using their high-
resolution imaging method, it would be
feasible for the first time to determine
if BBB leakage precedes white matter
damage, which is still unsettled in the
literature (Iadecola, 2013). Irrespective of
the many questions still outstanding,
Montagne et al. provide new evidence
for a pivotal role of neurovascular
dysfunction in the pathobiology of cog-
nitive impairment in humans and open
up new and exciting research directions
with great diagnostic and therapeutic
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The subthalamic nucleus-globus pallidus network is a potential source of oscillations in Parkinson’s disease,
but the mechanism is unknown. In this issue of Neuron, Chu et al. (2015) present a cortically driven form of
heterosynaptic plasticity that could promote oscillatory activity after dopamine depletion.Neuronal oscillations can synchronize
activity within networks and across brain
regions (Buzsa´ki and Draguhn, 2004).Although they are a healthy form of
communication in many brain areas,
their dysregulation is being increasinglyobserved in a number of diseases.
Abnormal, excessive oscillatory activity
in Parkinson’s disease (PD), for example,, January 21, 2015 ª2015 Elsevier Inc. 233
